Xu Qinzheng, Wu Di, Tan Jiachen, Khan Faheem Ahmed, Pandupuspitasari Nuruliarizki Shinta, Huang Chunjie
School of Medicine, Nantong University, Nantong, 226001, People's Republic of China.
Research Center for Animal Husbandry, National Research and Innovation Agency, Jakarta Pusat, 10340, Indonesia.
Drug Des Devel Ther. 2025 Aug 6;19:6719-6749. doi: 10.2147/DDDT.S511521. eCollection 2025.
Traditional Chinese medicines (TCMs) have been employed as a potent therapeutic modality within Chinese cultural contexts to address a spectrum of diseases. MicroRNAs (miRNAs) are endogenous, non-coding RNA (ncRNA) molecules that regulate genetic expression via post-transcriptional mechanisms. By modulating miRNA expression, TCMs have been proven to confer protective benefits, notably by facilitating apoptosis induction. Thus, exploring the molecular mechanisms implicating miRNAs within TCMs could offer potential avenues for developing novel strategies to mitigate various lethal illnesses. In this study, we aim to provide a concise overview delineating the contemporary understanding of the functions of TCMs in miRNA-mediated apoptosis across malignant and non-malignant pathologies, including cancer, neurological disorders, and cardiovascular diseases. This review will furnish valuable insights concerning the clinical utilization of TCMs in treatment and prevention across a spectrum of clinically relevant diseases and serve as a catalyst for the innovation of novel therapeutic agents to address these pathologies.
在中华文化背景下,传统中药一直被用作一种有效的治疗方式来应对一系列疾病。微小RNA(miRNA)是内源性非编码RNA(ncRNA)分子,通过转录后机制调节基因表达。通过调节miRNA表达,已证明中药具有保护作用,特别是通过促进细胞凋亡诱导。因此,探索中药中涉及miRNA的分子机制可为开发减轻各种致命疾病的新策略提供潜在途径。在本研究中,我们旨在简要概述目前对中药在miRNA介导的恶性和非恶性疾病(包括癌症、神经系统疾病和心血管疾病)细胞凋亡中的作用的理解。这篇综述将提供有关中药在一系列临床相关疾病的治疗和预防中的临床应用的宝贵见解,并作为创新新型治疗药物以解决这些疾病的催化剂。